BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16899306)

  • 1. Resveratrol inhibition of varicella-zoster virus replication in vitro.
    Docherty JJ; Sweet TJ; Bailey E; Faith SA; Booth T
    Antiviral Res; 2006 Dec; 72(3):171-7. PubMed ID: 16899306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honeysuckle-derived microRNA2911 directly inhibits varicella-zoster virus replication by targeting IE62 gene.
    Huang Y; Liu H; Sun X; Ding M; Tao G; Li X
    J Neurovirol; 2019 Aug; 25(4):457-463. PubMed ID: 31140131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner.
    Shakya AK; O'Callaghan DJ; Kim SK
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
    Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
    Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an anti-varicella-zoster virus compound that targets the portal protein encoded by ORF54.
    Yasui R; Yoshida C; Yamaguchi T; Inoue N
    Microbiol Immunol; 2017 Sep; 61(9):398-402. PubMed ID: 28833387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.
    Taylor SL; Kinchington PR; Brooks A; Moffat JF
    J Virol; 2004 Mar; 78(6):2853-62. PubMed ID: 14990704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibition of herpes simplex virus replication.
    Docherty JJ; Fu MM; Stiffler BS; Limperos RJ; Pokabla CM; DeLucia AL
    Antiviral Res; 1999 Oct; 43(3):145-55. PubMed ID: 10551373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interaction between two varicella zoster virus gene regulatory proteins, IE4 and IE62.
    Spengler ML; Ruyechan WT; Hay J
    Virology; 2000 Jul; 272(2):375-81. PubMed ID: 10873781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Characterization of the Serine-Rich Tract of Varicella-Zoster Virus IE62.
    Kim SK; Shakya AK; Kim S; O'Callaghan DJ
    J Virol; 2016 Jan; 90(2):959-71. PubMed ID: 26537679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling.
    Evers DL; Wang X; Huong SM; Huang DY; Huang ES
    Antiviral Res; 2004 Aug; 63(2):85-95. PubMed ID: 15302137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
    Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
    Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.
    Jones JO; Arvin AM
    Antiviral Res; 2005 Nov; 68(2):56-65. PubMed ID: 16118026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus infection of a human CD4-positive T-cell line.
    Zerboni L; Sommer M; Ware CF; Arvin AM
    Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
    J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium chloride suppresses the synthesis of messenger RNA for infected cell protein-4 and viral deoxyribonucleic acid polymerase in herpes simplex virus-1 infected endothelial cells.
    Ziaie Z; Brinker JM; Kefalides NA
    Lab Invest; 1994 Jan; 70(1):29-38. PubMed ID: 8302016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71.
    Wu BW; Yee MB; Goldstein RS; Kinchington PR
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.